SCM
CGON icon

Sterling Capital Management’s CG Oncology CGON Stock Holding History

Sterling Capital Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Sell
259
-124
-32% -$8.11K ﹤0.01% 1921
2026
Q1 		$25.9K Buy
383
+18
+5% +$1.02K ﹤0.01% 1902
2025
Q4 		$15.2K Buy
365
+230
+170% +$9.52K ﹤0.01% 2385
2025
Q3 		$5.44K Hold
135
– – ﹤0.01% 2748
2025
Q2 		$3.51K Sell
135
-270
-67% -$6.51K ﹤0.01% 2707
2025
Q1 		$9.92K Sell
405
-227
-36% -$6.39K ﹤0.01% 1863
2024
Q4 		$18.1K Buy
632
+540
+587% +$18.5K ﹤0.01% 1901
2024
Q3 		$3.47K Buy
+92
New +$3.23K ﹤0.01% 1918

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sterling Capital Management's CGON Position: Q2 2026 in Review

Sterling Capital Management reduced its CG Oncology (CGON) stake by 32% in Q2 2026, selling an estimated $8.11K and leaving 259 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Sterling Capital Management first reported a position in CGON in Q3 2024 and has held it in 8 quarters since. The position peaked at $25.9K in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Sterling Capital Management held 259 shares of CG Oncology worth $18.4K as of Q2 2026.
  • Sterling Capital Management sold 124 CG Oncology shares in Q2 2026, an estimated $8.11K.
  • CG Oncology made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1921 holding.
  • Sterling Capital Management first reported a position in CG Oncology in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's CG Oncology position peaked at $25.9K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.